BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8462860)

  • 1. Twice-daily peak expiratory flow rate monitoring for the assessment of childhood asthma.
    Linna OV
    Allergy Proc; 1993; 14(1):33-6. PubMed ID: 8462860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirometry, bronchodilator test or symptom scoring for the assessment of childhood asthma.
    Linna O
    Acta Paediatr; 1996 May; 85(5):564-9. PubMed ID: 8827100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirometric patterns in childhood asthma: peak flow compared with other indices.
    Klein RB; Fritz GK; Yeung A; McQuaid EL; Mansell A
    Pediatr Pulmonol; 1995 Dec; 20(6):372-9. PubMed ID: 8649917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma?
    Malo JL; L'Archevêque J; Trudeau C; d'Aquino C; Cartier A
    J Allergy Clin Immunol; 1993 Mar; 91(3):702-9. PubMed ID: 8454792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic.
    Gautrin D; D'Aquino LC; Gagnon G; Malo JL; Cartier A
    Chest; 1994 Nov; 106(5):1419-26. PubMed ID: 7956394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between changes in diurnal variation of expiratory flows, lung volumes and respiratory symptoms after acute asthma.
    Boulet LP; Milot J; Turcotte H
    Respir Med; 1991 Nov; 85(6):487-93. PubMed ID: 1775675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies.
    Bheekie A; Syce JA; Weinberg EG
    J Clin Pharm Ther; 2001 Aug; 26(4):287-96. PubMed ID: 11493372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial.
    Carter ER; Webb CR; Moffitt DR
    Chest; 1996 May; 109(5):1256-61. PubMed ID: 8625677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
    Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR
    Thorax; 1996 Jul; 51(7):664-9. PubMed ID: 8882070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home peak expiratory flow rate monitoring in patients with asthma.
    Li JT
    Mayo Clin Proc; 1995 Jul; 70(7):649-56. PubMed ID: 7791387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Dutch CNSLD Study Group.
    Brand PL; Duiverman EJ; Postma DS; Waalkens HJ; Kerrebijn KF; van Essen-Zandvliet EE
    Eur Respir J; 1997 Jun; 10(6):1242-7. PubMed ID: 9192923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of peak expiratory flow rate for diagnosing bronchial obstruction on methacholine inhalation challenge in school-aged asthmatic children.
    Linna O
    Acta Paediatr; 1998 Jun; 87(6):635-7. PubMed ID: 9686655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal variation of peak expiratory flow rate in asthmatic children.
    Sly PD; Hibbert ME; Landau LI
    Pediatr Pulmonol; 1986; 2(3):141-6. PubMed ID: 3737275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates.
    Ferguson AC
    J Allergy Clin Immunol; 1988 Jul; 82(1):19-22. PubMed ID: 3392366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on peak expiratory flow monitoring maneuver as compared to forced expiratory flow maneuver].
    Nagasaka Y; Fujita E; Hazu R; Nishimura N; Nakajima S
    Arerugi; 1996 Jan; 45(1):34-40. PubMed ID: 8851314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function in symptom-free asthmatics.
    Yaacob I; Mohammad M
    Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adding nedocromil sodium (Tilade) to the routine therapy of patients with bronchial asthma.
    Fyans PG; Chatterjee PC; Chatterjee SS
    Clin Exp Allergy; 1989 Sep; 19(5):521-8. PubMed ID: 2551469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate.
    Hetzel MR; Clark TJ
    Thorax; 1980 Oct; 35(10):732-8. PubMed ID: 7466721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.